Cargando…

Effect of PCSK9 inhibition in combination with statin therapy on intracranial atherosclerotic stenosis: A high-resolution MRI study

INTRODUCTION: Intracranial atherosclerotic stenosis (ICAS) is a common cause of stroke worldwide. Evolocumab, a proprotein convertase subtilisin/kexin type-9 inhibitor (PCSK9i), effectively lowers low-density lipoprotein (LDL) and produces favorable changes in coronary atherosclerosis. This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Lingshan, Kong, Qianqian, Huang, Hao, Xu, Shabei, Qu, Wensheng, Zhang, Ping, Yu, Zhiyuan, Luo, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033935/ https://www.ncbi.nlm.nih.gov/pubmed/36967822 http://dx.doi.org/10.3389/fnagi.2023.1127534

Ejemplares similares

Case Report: Advantages of High-Resolution MRI in Evaluating the Efficacy of Drug Therapy for Intracranial Atherosclerotic Plaques
por: Zheng, Tao, et al.
Publicado: (2022)

Characterization of intracranial atherosclerotic stenosis using high‐resolution MRI study – rationale and design
por: Turan, Tanya N., et al.
Publicado: (2015)

Asymmetry of Lacunae between Brain Hemispheres Is Associated with Atherosclerotic Occlusions of Middle Cerebral Artery
por: Wu, Lingshan, et al.
Publicado: (2023)

High-Resolution MRI of Intracranial Atherosclerotic Disease
por: Ryu, Chang-Woo, et al.
Publicado: (2014)

A High-Resolution MRI Study of the Relationship Between Plaque Enhancement and Ischemic Stroke Events in Patients With Intracranial Atherosclerotic Stenosis
por: Wang, ErLing, et al.
Publicado: (2019)

Chitinase-3 like-protein-1, matrix metalloproteinase -9 and positive intracranial arterial remodelling
por: Tang, Ming, et al.
Publicado: (2023)

Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study)
por: LIU, Yu-Qi, et al.
Publicado: (2021)

Elevated RANTES levels are associated with increased risk of cerebral atherosclerotic stenosis
por: Guo, Yinping, et al.
Publicado: (2023)

Adoption of PCSK9 Inhibitors Among Patients With Atherosclerotic Disease
por: Dayoub, Elias J., et al.
Publicado: (2021)

Pharmacological Strategies beyond Statins: Ezetimibe and PCSK9 Inhibitors
por: Choi, Jah Yeon, et al.
Publicado: (2019)

Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation
por: LaFratte, Christopher, et al.
Publicado: (2023)

Case report: Intensive statin and PCSK-9 inhibitor combo reduces plaque volume and stenosis in ischemic stroke patient
por: Zeng, Weiqi, et al.
Publicado: (2023)

Application of High-Resolution Flat Detector Computed Tomography in Stent Implantation for Intracranial Atherosclerotic Stenosis
por: Li, Tengfei, et al.
Publicado: (2021)

Functional evaluation of intracranial atherosclerotic stenosis by pressure ratio measurements
por: Wang, Ming, et al.
Publicado: (2023)

Elevated homocysteine as an independent risk for intracranial atherosclerotic stenosis
por: Liu, Ying, et al.
Publicado: (2019)

Importance of lipid ratios for predicting intracranial atherosclerotic stenosis
por: Yang, Wen-Song, et al.
Publicado: (2020)

Is the future of symptomatic intracranial atherosclerotic stenosis management promising?
por: Liu, Dacheng, et al.
Publicado: (2020)

Association of peripheral neutrophil count with intracranial atherosclerotic stenosis
por: Zhang, Xing, et al.
Publicado: (2020)

Prevalence, prognosis, and treatment of atherosclerotic intracranial stenosis in Caucasians
por: Hurford, Robert, et al.
Publicado: (2020)

Plasma PCSK9 levels are significantly modified by statins and fibrates in humans
por: Mayne, Janice, et al.
Publicado: (2008)

Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment
por: Sliz, Eeva, et al.
Publicado: (2018)

Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
por: Barkas, Fotios, et al.
Publicado: (2021)

Serum Cortisol Is Associated With Cerebral Small Vessel Disease-Related Brain Changes and Cognitive Impairment
por: Qiu, Qianwen, et al.
Publicado: (2022)

Associations of neutrophil-to-lymphocyte ratio with intracranial and extracranial atherosclerotic stenosis
por: Xie, Yu, et al.
Publicado: (2022)

Qualitative and quantitative plaque enhancement on high‐resolution vessel wall imaging predicts symptomatic intracranial atherosclerotic stenosis
por: Huang, Li‐Xin, et al.
Publicado: (2023)

Morphologic characteristics of severe basilar artery atherosclerotic stenosis on 3D high-resolution MRI
por: Guo, Runcai, et al.
Publicado: (2018)

Circulating Mature PCSK9 Level Predicts Diminished Response to Statin Therapy
por: Kuyama, Naoto, et al.
Publicado: (2021)

The Effect of Intensive Statin Therapy on Symptomatic Intracranial Arterial Stenosis
por: ZHOU, Peiyang, et al.
Publicado: (2018)

PCSK9 and Calcific Aortic Valve Stenosis: Moving Beyond Lipids
por: Leopold, Jane A.
Publicado: (2020)

Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis
por: Perrot, Nicolas, et al.
Publicado: (2020)

Effect of PCSK9 on atherosclerotic cardiovascular diseases and its mechanisms: Focus on immune regulation
por: Ma, Minglu, et al.
Publicado: (2023)

Safety of Low-Dose Aspirin in Endovascular Treatment for Intracranial Atherosclerotic Stenosis
por: Ma, Ning, et al.
Publicado: (2014)

Treatment and imaging of intracranial atherosclerotic stenosis: current perspectives and future directions
por: van den Wijngaard, Ido R., et al.
Publicado: (2016)

Endovascular Treatment of Intracranial Atherosclerotic Stenosis: Current Debates and Future Prospects
por: Luo, Jichang, et al.
Publicado: (2018)

Association of Systolic Blood Pressure with Progression of Symptomatic Intracranial Atherosclerotic Stenosis
por: Park, Jong-Ho, et al.
Publicado: (2017)

A Need for Tailored Approach for Patients with Symptomatic Intracranial Atherosclerotic Stenosis
por: Kate, Mahesh P., et al.
Publicado: (2020)

Enterprise stent for symptomatic complex intracranial atherosclerotic stenosis: safety and efficiency
por: Dong, Yanhua, et al.
Publicado: (2019)

Radiomics Nomogram for Predicting Stroke Recurrence in Symptomatic Intracranial Atherosclerotic Stenosis
por: Tang, Min, et al.
Publicado: (2022)

The lymphocyte-to-monocyte ratio predicts intracranial atherosclerotic stenosis plaque instability
por: Wu, Xiao-Bing, et al.
Publicado: (2022)

Independent association of PCSK9 with platelet reactivity in subjects without statin or antiplatelet agents
por: Wang, Shuai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3voarnuetlncb3i2117rp36faa